TheraVac-01: Evaluation of Safety and Immunogenicity of the HIV-1 Vaccine NYVAC-B in Chronic HIV-1 Infected Patients Successfully Treated with HAART

被引：0
|
作者：
Bart, P-A [1 ]
Harari, A. [1 ]
Vermeulen, J. N. [2 ,3 ]
Enders, F. Bellutti [1 ]
Bataenjer, E. Castro [1 ]
Cavassini, M. [1 ]
Wit, F. W. [2 ,3 ]
Autran, B. [4 ]
Lange, J. M. [2 ,3 ]
Pantaleo, G. [1 ]
机构：
[1] CHU Vaudois, Lausanne, Switzerland
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[3] IATEC, Amsterdam, Netherlands
[4] Fac Med Pierre & Marie Curie, Paris, France
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2008年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [41] Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users
    Amendola, A
    Tanzi, E
    Zappa, A
    Colzani, D
    Boschini, A
    Musher, DM
    Zanetti, AR
    VACCINE, 2002, 20 (31-32) : 3720 - 3724
  • [42] Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients
    Moragas, M.
    Belloso, W. H.
    Baquedano, M. S.
    Gutierrez, M. I.
    Bissio, E.
    Larriba, J. M.
    Fay, F.
    Aulicino, P.
    Gurevich, J. M.
    Yaunguzian, M. F.
    Maldonado, A. C.
    Falistocco, C.
    Sen, L.
    Mangano, A.
    TISSUE ANTIGENS, 2015, 86 (01): : 28 - 31
  • [43] Rapid progression of carotid lesions in HAART-treated HIV-1 patients
    Maggi, Paolo
    Perilli, Francesco
    Lillo, Antonio
    Gargiulo, Miriam
    Ferraro, Sergio
    Grisorio, Benvenuto
    Ferrara, Sergio
    Carito, Valentina
    Bellacosa, Chiara
    Pastore, Giuseppe
    Chirianni, Antonio
    Regina, Guido
    ATHEROSCLEROSIS, 2007, 192 (02) : 407 - 412
  • [44] Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B′ HIV-1 Candidate Vaccine
    Vasan, Sandhya
    Schlesinger, Sarah J.
    Huang, Yaoxing
    Hurley, Arlene
    Lombardo, Angela
    Chen, Zhiwei
    Than, Soe
    Adesanya, Phumla
    Bunce, Catherine
    Boaz, Mark
    Boyle, Rosanne
    Sayeed, Eddy
    Clark, Lorna
    Dugin, Daniel
    Schmidt, Claudia
    Song, Yang
    Seamons, Laura
    Dally, Len
    Ho, Martin
    Smith, Carol
    Markowitz, Martin
    Cox, Josephine
    Gill, Dilbinder K.
    Gilmour, Jill
    Keefer, Michael C.
    Fast, Patricia
    Ho, David D.
    PLOS ONE, 2010, 5 (01):
  • [45] HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients
    Re, M. C.
    Vitone, F.
    Biagetti, C.
    Schiavone, P.
    Alessandrini, F.
    Bon, I.
    de Crignis, E.
    Gibellini, D.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) : 640 - 646
  • [46] Humoral immunogenicity of 2009 pandemic influenza A H1N1v adjuvanted vaccine in HIV-1 infected patients treated with Maraviroc
    Canestri, A.
    Le Corre, M.
    Krivine, A.
    Assoumou, L.
    Rozenberg, F.
    Ben-Abdallah, S.
    Calvez, V.
    Schneider, L.
    Samri, A.
    Guislaine, C.
    Autran, B.
    Katlama, C.
    Guihot, A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A52 - A52
  • [47] Immunogenicity of lyophilized MVA vaccine for HIV-1 in mice model
    Zhang Zi-zhe
    Jiang Chun-lai
    Yu Xiang-hui
    Lou Chao-ping
    Zhao Dong-hai
    Wu Yong-ge
    Jin Ying-hua
    Liu Cheng-shan
    Kong Wei
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2007, 23 (03) : 329 - 332
  • [48] Immunogenicity of a recombinant measles HIV-1 subtype C vaccine
    Stebbings, Richard
    Li, Bo
    Lorin, Clarisse
    Koutsoukos, Marguerite
    Fevrier, Michele
    Mee, Edward T.
    Page, Mark
    Almond, Neil
    Tangy, Frederic
    Voss, Gerald
    VACCINE, 2013, 31 (51) : 6079 - 6086
  • [49] Immunogenicity of Lyophilized MVA Vaccine for HIV-1 in Mice Model
    ZHANG Yi-zhe
    Chemical Research in Chinese Universities, 2007, (03) : 329 - 332
  • [50] Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA:: safety, immunogenicity and influence on viral load during treatment interruption
    Harrer, E
    Bäuerle, M
    Ferstl, B
    Chaplin, P
    Petzold, B
    Mateo, L
    Handley, A
    Tzatzaris, M
    Vollmar, J
    Bergmann, S
    Rittmaier, M
    Eismann, K
    Müller, S
    Kalden, JR
    Spriewald, B
    Willbold, D
    Harrer, T
    ANTIVIRAL THERAPY, 2005, 10 (02) : 285 - 300
12345